The atypical neuroleptics iloperidone and lurasidone inhibit human cytochrome P450 enzymes in vitro. Evaluation of potential metabolic interactions

Documenti analoghi

• In vitro inhibition of human cytochrome P450 enzymes by the novel atypical antipsychotic drug asenapine: a prediction of possible drug–drug interactions
  di: Wójcikowski, Jacek, et al.
  Pubblicazione: (2020)
• Levomepromazine and clozapine induce the main human cytochrome P450 drug metabolizing enzyme CYP3A4
  di: Danek, Przemysław J., et al.
  Pubblicazione: (2020)
• Contribution of human cytochrome P-450 isoforms to the metabolism of the simplest phenothiazine neuroleptic promazine
  di: Wójcikowski, Jacek, et al.
  Pubblicazione: (2003)
• Correction: Danek, P.J.; Daniel, W.A. Long-Term Treatment with Atypical Antipsychotic Iloperidone Modulates Cytochrome P450 2D (CYP2D) Expression and Activity in the Liver and Brain via Different Mechanisms. <i>Cells</i> 2021, <i>10</i>, 3472
  di: Przemysław J. Danek, et al.
  Pubblicazione: (2024-12-01)
• Characterisation of the cytochrome P450 enzymes involved in the in vitro metabolism of granisetron.
  di: Bloomer, J C, et al.
  Pubblicazione: (1994)